Description
The innovators developed a means for intravesical drug delivery by which specific drug-carrier compositions wherein the drug is a therapeutic oligonucleotide and the carrier is a commercially available protamine injection solution.
IP Status
https://patents.google.com/patent/US20210052734A1
